These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26464271)

  • 1. Effect of transmembrane pressure on Factor VIII yield in ATF perfusion culture for the production of recombinant human Factor VIII co-expressed with von Willebrand factor.
    Kim SC; An S; Kim HK; Park BS; Na KH; Kim BG
    Cytotechnology; 2016 Oct; 68(5):1687-96. PubMed ID: 26464271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified harvest system for enhancing Factor VIII yield in alternating tangential flow perfusion culture.
    Kim SC; An S; Kim HK; Park BS; Na KH; Kim BG
    J Biosci Bioeng; 2016 May; 121(5):561-5. PubMed ID: 26906934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized process operations reduce product retention and column clogging in ATF-based perfusion cell cultures.
    Su Y; Wei Z; Miao Y; Sun L; Shen Y; Tang Z; Li L; Quan Y; Yu H; Wang WC; Zhou W; Tian J
    Appl Microbiol Biotechnol; 2021 Dec; 105(24):9125-9136. PubMed ID: 34811605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.
    Genzel Y; Vogel T; Buck J; Behrendt I; Ramirez DV; Schiedner G; Jordan I; Reichl U
    Vaccine; 2014 May; 32(24):2770-81. PubMed ID: 24583003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inner diameter, filter length, and pore size on hollow fiber filter fouling during perfusion cell culture.
    WuDunn D; Squeri A; Vu J; Dhingra A; Coffman J; Lee K
    Biotechnol Prog; 2024; 40(3):e3440. PubMed ID: 38343012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.
    Furuya K; Murai K; Yokoyama T; Maeno H; Takeda Y; Murozuka T; Wakisaka A; Tanifuji M; Tomono T
    Vox Sang; 2006 Aug; 91(2):119-25. PubMed ID: 16907872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.
    Kolind MP; Nørby PL; Berchtold MW; Johnsen LB
    J Biotechnol; 2011 Feb; 151(4):357-62. PubMed ID: 21219947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIII and factor VIII-von Willebrand factor complex do not present danger signals for human dendritic cells.
    Pfistershammer K; Stöckl J; Siekmann J; Turecek PL; Schwarz HP; Reipert BM
    Thromb Haemost; 2006 Sep; 96(3):309-16. PubMed ID: 16953272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
    Jones TR; Kao KJ; Pizzo SV; Bigner DD
    Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved sieving coefficient in perfusion cell culture with reduced effective filtration length of hollow fibers.
    Vu J; Gadberry JA; Coffman J; Lee K
    Biotechnol Prog; 2024 Apr; ():e3472. PubMed ID: 38655754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
    Johnstone IB; Crane S
    Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Larger Pore Size Hollow Fiber Membranes as a Solution to the Product Retention Issue in Filtration-Based Perfusion Bioreactors.
    Wang SB; Godfrey S; Radoniqi F; Lin H; Coffman J
    Biotechnol J; 2019 Feb; 14(2):e1800137. PubMed ID: 30024094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor VIII/von Willebrand factor complex: basic and clinical issues.
    Federici AB
    Haematologica; 2003 Jun; 88(6):EREP02. PubMed ID: 12826528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seminal Factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?
    Lwaleed BA; Greenfield R; Royle E; Birch B; Cooper AJ
    Int J Androl; 2005 Feb; 28(1):31-8. PubMed ID: 15679619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
    Switzer ME; McKee PA
    J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of an acoustic settler versus a hollow fiber-based ATF technology for influenza virus production in perfusion.
    Gränicher G; Coronel J; Trampler F; Jordan I; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4877-4888. PubMed ID: 32291490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.